Microphysiological systems for studying neuroplasticity and cerebral microcirculation
- Authors: Salmina A.B.1,2, Averchuk A.S.1,2, Komleva Y.K.1,2, Kolotyeva N.A.1,2, Rozanova N.A.1,2, Potapenko I.V.1,2, Alexandrova O.P.1, Lifanov D.A.1,2, Abaimov D.A.1,2, Dragun M.A.2, Kushnir I.A.2, Korsakovа S.A.2, Yurchenko S.O.2, Illarioshkin S.N.1
-
Affiliations:
- Russian Сenter of Neurology and Neurosciences
- Moscow State Technical University named after N.E. Bauman
- Issue: Vol 81, No 1 (2026)
- Pages: 14-22
- Section: NEUROLOGY AND NEUROSURGERY: CURRENT ISSUES
- Published: 16.05.2026
- URL: https://vestnikramn.spr-journal.ru/jour/article/view/18166
- DOI: https://doi.org/10.15690/vramn18166
- ID: 18166
Cite item
Abstract
This review systematizes modern bioengineering strategies for modeling tissue barriers, neurovascular unit (NVU) and perivascular unit (PVU) for translational neuroscience. The aim is to provide a critical analysis of the current understandings of neuroplasticity, organization of NVU, PVU and blood-brain barrier as well as advantages and limitations of currently available in vitro microphysiological models. It is clear that, despite progress in replicating three-dimensional architecture, the next key challenge is to imitate the temporal dynamics of histogenesis (angiogenesis, barrierogenesis, neurogenesis). This defines the transition towards the development of a novel class of 4D models capable of spatiotemporal self-organization. The analysis reveals the necessity to adapt model complexity to the target function: highly complex systems are a priority for fundamental research into plasticity and pathogenesis of nervous system disorders, while standardized platforms are well-suited for high-throughput pharmacological screening. It is concluded that creating relevant, validated platforms remains a critical interdisciplinary task. This will help bridge the gap between preclinical and clinical research, enhancing the reliability of studying pathological mechanisms and the preclinical evaluation of therapeutic agents.
Full Text
About the authors
Alla B. Salmina
Russian Сenter of Neurology and Neurosciences; Moscow State Technical University named after N.E. Bauman
Author for correspondence.
Email: allasalmina@mail.ru
ORCID iD: 0000-0003-4012-6348
SPIN-code: 6504-7657
MD, PhD, Professor, Corresponding Member of the RAS
Russian Federation, Moscow; MoscowAnton S. Averchuk
Russian Сenter of Neurology and Neurosciences; Moscow State Technical University named after N.E. Bauman
Email: antonaverchuk@yandex.ru
ORCID iD: 0000-0002-1284-6711
SPIN-code: 7276-8713
PhD in Biology, Assistant Professor
Russian Federation, Moscow; MoscowYulia K. Komleva
Russian Сenter of Neurology and Neurosciences; Moscow State Technical University named after N.E. Bauman
Email: yuliakomleva@mail.ru
ORCID iD: 0000-0001-5742-8356
SPIN-code: 1585-8130
MD, PhD
Russian Federation, Moscow; MoscowNatalia A. Kolotyeva
Russian Сenter of Neurology and Neurosciences; Moscow State Technical University named after N.E. Bauman
Email: bortnikova.n@gmail.com
SPIN-code: 5815-0989
MD, PhD, Assistant Professor
Russian Federation, Moscow; MoscowNatalia A. Rozanova
Russian Сenter of Neurology and Neurosciences; Moscow State Technical University named after N.E. Bauman
Email: nataliarozanovaa@gmail.com
ORCID iD: 0000-0001-9619-4679
SPIN-code: 7696-1738
Russian Federation, Moscow; Moscow
Ilya V. Potapenko
Russian Сenter of Neurology and Neurosciences; Moscow State Technical University named after N.E. Bauman
Email: iluminator@snkip.ru
ORCID iD: 0000-0001-9743-8700
SPIN-code: 4229-9507
PhD
Russian Federation, Moscow; MoscowOlga P. Alexandrova
Russian Сenter of Neurology and Neurosciences
Email: molka-molka@yandex.ru
ORCID iD: 0009-0006-9109-1463
SPIN-code: 2705-7186
PhD in Biology
Russian Federation, MoscowDmitry A. Lifanov
Russian Сenter of Neurology and Neurosciences; Moscow State Technical University named after N.E. Bauman
Email: dmtlifnv@gmail.com
ORCID iD: 0009-0001-6127-8044
SPIN-code: 5367-8372
Russian Federation, Moscow; Moscow
Denis A. Abaimov
Russian Сenter of Neurology and Neurosciences; Moscow State Technical University named after N.E. Bauman
Email: abaimov@neurology.ru
ORCID iD: 0000-0001-6888-3223
SPIN-code: 7548-0933
PhD in Biology
Russian Federation, Moscow; MoscowMaksim A. Dragun
Moscow State Technical University named after N.E. Bauman
Email: drmaksim@icloud.com
ORCID iD: 0000-0002-2319-4894
SPIN-code: 5400-0828
Russian Federation, Moscow
Ivan A. Kushnir
Moscow State Technical University named after N.E. Bauman
Email: ivankushnir.x@gmail.com
ORCID iD: 0009-0007-5034-6244
SPIN-code: 2083-6046
Russian Federation, Moscow
Sofia A. Korsakovа
Moscow State Technical University named after N.E. Bauman
Email: sofia.korsakova@gmail.com
ORCID iD: 0000-0001-9269-8300
SPIN-code: 6918-5588
Russian Federation, Moscow
Stanislav O. Yurchenko
Moscow State Technical University named after N.E. Bauman
Email: st.yurchenko@mail.ru
ORCID iD: 0000-0001-6821-904X
SPIN-code: 3313-1005
PhD in Physical and Mathematical Sciences, Professor
Russian Federation, MoscowSergey N. Illarioshkin
Russian Сenter of Neurology and Neurosciences
Email: illarioshkin@neurology.ru
ORCID iD: 0000-0002-2704-6282
SPIN-code: 8646-9426
MD, PhD, Professor, Academician of the RAS
Russian Federation, MoscowReferences
- Koch G, Spampinato D. Alzheimer disease and neuroplasticity. Handb Clin Neurol. 2022;184:473–479. doi: https://doi.org/10.1016/B978-0-12-819410-2.00027-8
- Paro MR, Chakraborty AR, Angelo S, et al. Molecular mediators of angiogenesis and neurogenesis after ischemic stroke. Rev Neurosci. 2022;34(4):425–442. doi: https://doi.org/10.1515/revneuro-2022-0049
- Salmina AB, Kharitonova EV, Gorina YV, et al. Blood-Brain Barrier and Neurovascular Unit In Vitro Models for Studying Mitochondria-Driven Molecular Mechanisms of Neurodegeneration. Int J Mol Sci. 2021;22(9):4661. doi: https://doi.org/10.3390/ijms22094661
- Loryan I, Hammarlund-Udenaes M, Syvänen S. Brain Distribution of Drugs: Pharmacokinetic Considerations. Handb Exp Pharmacol. 2022;273:121–150. doi: https://doi.org/10.1007/164_2020_405
- Tregub PP, Averchuk AS, Baranich TI, et al. Physiological and Pathological Remodeling of Cerebral Microvessels. Int J Mol Sci. 2022;23(20):12683. doi: https://doi.org/10.3390/ijms232012683
- Kumar NN, Pizzo ME, Nehra G, et al. Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New Approaches. Bioconjug Chem. 2018;29(12):3937–3966. doi: https://doi.org/10.1021/acs.bioconjchem.8b00548
- Gupta M, Feng J, Bhisetti G. Experimental and Computational Methods to Assess Central Nervous System Penetration of Small Molecules. Molecules. 2024;29(6):1264. doi: https://doi.org/10.3390/molecules29061264
- Miller K. Biomechanics of soft tissues. Med Sci Monit. 2000;6(1):158–167.
- Tanigami H, Okamoto T, Yasue Y, et al. Astroglial integrins in the development and regulation of neurovascular units. Pain Res Treat. 2012;2012:964652. doi: https://doi.org/10.1155/2012/964652
- Troili F, Cipollini V, Moci M, et al. Perivascular Unit: This Must Be the Place. The Anatomical Crossroad between the Immune, Vascular and Nervous System. Front Neuroanat. 2020;14:17. doi: https://doi.org/10.3389/fnana.2020.00017
- Lohela TJ, Lilius TO, Nedergaard M. The glymphatic system: implications for drugs for central nervous system diseases. Nat Rev Drug Discov. 2022;21(10):763–779. doi: https://doi.org/10.1038/s41573-022-00500-9
- Pozhilenkova EA, Lopatina OL, Komleva YK, et al. Blood-brain barrier-supported neurogenesis in healthy and diseased brain. Rev Neurosci. 2017;28(4):397–415. doi: https://doi.org/10.1515/revneuro-2016-0071
- Bressan C, Saghatelyan A. Intrinsic Mechanisms Regulating Neuronal Migration in the Postnatal Brain. Front Cell Neurosci. 2021;14:620379. doi: https://doi.org/10.3389/fncel.2020.620379
- James R, Kim Y, Hockberger PE, et al. Subventricular zone cell migration: lessons from quantitative two-photon microscopy. Front Neurosci. 2011;5:30. doi: https://doi.org/10.3389/fnins.2011.00030
- Lange C, Turrero Garcia M, Decimo I, et al. Relief of hypoxia by angiogenesis promotes neural stem cell differentiation by targeting glycolysis. EMBO J. 2016;35(9):924–941. doi: https://doi.org/10.15252/embj.201592372
- Hatakeyama M, Ninomiya I, Kanazawa M. Angiogenesis and neuronal remodeling after ischemic stroke. Neural Regen Res. 2020;15(1):16–19. doi: https://doi.org/10.4103/1673-5374.264442
- Bonfanti L, La Rosa C, Ghibaudi M, et al. Adult neurogenesis and “immature” neurons in mammals: an evolutionary trade-off in plasticity? Brain Struct Funct. 2024;229(8):1775–1793. doi: https://doi.org/10.1007/s00429-023-02717-9
- Perosa V, Priester A, Ziegler G, et al. Hippocampal vascular reserve associated with cognitive performance and hippocampal volume. Brain. 2020;143(2):622–634. doi: https://doi.org/10.1093/brain/awz383
- Pulga A, Porte Y, Morel JL. Changes in C57BL6 Mouse Hippocampal Transcriptome Induced by Hypergravity Mimic Acute Corticosterone-Induced Stress. Front Mol Neurosci. 2016;9:153. doi: https://doi.org/10.3389/fnmol.2016.00153
- Abbott NJ, Friedman A. Overview and introduction: the blood-brain barrier in health and disease. Epilepsia. 2012;53(6):1–6. doi: https://doi.org/10.1111/j.1528-1167.2012.03696.x
- Figley CR, Stroman PW. The role(s) of astrocytes and astrocyte activity in neurometabolism, neurovascular coupling, and the production of functional neuroimaging signals. Eur J Neurosci. 2011;33(4):577–588. doi: https://doi.org/10.1111/j.1460-9568.2010.07584.x
- Filosa JA. Vascular tone and neurovascular coupling: considerations toward an improved in vitro model. Front Neuroenergetics. 2010;2:16. doi: https://doi.org/10.3389/fnene.2010.00016
- Tarasoff-Conway JM, Carare RO, Osorio RS, et al. Clearance systems in the brain — implications for Alzheimer disease. Nat Rev Neurol. 2015;11:457–470. doi: https://doi.org/10.1038/nrneurol.2015.119
- Kim KJ, Ramiro DJ, Iddings JA, et al. Vasculo-Neuronal Coupling: Retrograde Vascular Communication to Brain Neurons. J Neurosci. 2016;36:12624–12639. doi: https://doi.org/10.1523/JNEUROSCI.1300-16.2016
- Andreone BJ, Lacoste B, Gu C. Neuronal and vascular interactions. Annu Rev Neurosci. 2015;38:25–46. doi: https://doi.org/10.1146/annurev-neuro-071714-033835
- Zhao Z, Nelson AR, Betsholtz C, et al. Establishment and Dysfunction of the Blood-Brain Barrier. Cell. 2015;163(5):1064–1078. doi: https://doi.org/10.1016/j.cell.2015.10.067
- Castro DM, Mapunda JA, Vladymyrov M, et al. Structure and Junctional Complexes of Endothelial, Epithelial and Glial Brain Barriers. Int J Mol Sci. 2019;20(21):5372. doi: https://doi.org/10.3390/ijms20215372
- Osipova ED, Semyachkina-Glushkovskaya OV, Morgun AV, et al. Gliotransmitters and cytokines in the control of blood-brain barrier permeability. Rev Neurosci. 2018;29(5):567–591. doi: https://doi.org/10.1515/revneuro-2017-0092
- Khadka B, Lee JY, Park EK, et al. Impacts of Drug Interactions on Pharmacokinetics and the Brain Transporters: A Recent Review of Natural Compound-Drug Interactions in Brain Disorders. Int J Mol Sci. 2021;22(4):1809. doi: https://doi.org/10.3390/ijms22041809
- Hashimoto Y, Campbell M. Eyes on glutamate in angiogenesis and barrier formation. Neuron. 2024;112(12):1895–1897. doi: https://doi.org/10.1016/j.neuron.2024.05.020
- Zhdankina VI, Perepelitsa ES, Blagova AV, et al. The involvement of HIF-1α-dependent paracrine factors in Alzheimer’s disease. Rev Neurosci. 2025. doi: https://doi.org/10.1515/revneuro-2025-0102
- Salmina AB, Saridis MR, Ryzhkov VV, et al. Development of microvascular network in microfluidic brain-on-a-chip models in vitro: a multidisciplinary review. Biotechnol J. 2025;20(10):e70126. doi: https://doi.org/10.1002/biot.70126
- Biron KE, Dickstein DL, Gopaul R, et al. Amyloid triggers extensive cerebral angiogenesis causing blood brain barrier permeability and hypervascularity in Alzheimer’s disease. PLoS One. 2011;6(8):e23789. doi: https://doi.org/10.1371/journal.pone.0023789
- Alvarez-Vergara MI, Rosales-Nieves AE, March-Diaz R, et al. Non-productive angiogenesis disassembles Aß plaque-associated blood vessels. Nat Commun. 2021;12(1):3098. doi: https://doi.org/10.1038/s41467-021-23337-z
- Averchuk AS, Ryazanova MV, Baranich TI, et al. The Neurotoxic Effect of β-Amyloid Is Accompanied by Changes in the Mitochondrial Dynamics and Autophagy in Neurons and Brain Endothelial Cells in the Experimental Model of Alzheimer’s Disease. Bull Exp Biol Med. 2023;175(3):315–320. doi: https://doi.org/10.1007/s10517-023-05859-2
- Baranich TI, Averchuk AS, Kukla MV, et al. Subpopulation Alterations of Vascular Endothelial Cells in the Cerebral Cortex in Experimental Models of Alzheimer’s Disease. Bull Exp Biol Med. 2025;178(3):371–375. doi: https://doi.org/10.1007/s10517-025-06339-5
- Singh CSB, Choi KB, Munro L, et al. Reversing pathology in a preclinical model of Alzheimer’s disease by hacking cerebrovascular neoangiogenesis with advanced cancer therapeutics. EBioMedicine. 2021;71:103503. doi: https://doi.org/10.1016/j.ebiom.2021.103503
- Ogaki A, Ikegaya Y, Koyama R. Vascular Abnormalities and the Role of Vascular Endothelial Growth Factor in the Epileptic Brain. Front Pharmacol. 2020;11:20. doi: https://doi.org/10.3389/fphar.2020.00020
- Boitsova EB, Morgun AV, Osipova ED, et al. The inhibitory effect of LPS on the expression of GPR81 lactate receptor in blood-brain barrier model in vitro. J Neuroinflammation. 2018;15(1):196. doi: https://doi.org/10.1186/s12974-018-1233-2
- Salmina AB, Gorina YV, Komleva YK, et al. Early Life Stress and Metabolic Plasticity of Brain Cells: Impact on Neurogenesis and Angiogenesis. Biomedicines. 2021;9(9):1092. doi: https://doi.org/10.3390/biomedicines9091092
- Moya ELJ, Vandenhaute E, Rizzi E, et al. Miniaturization and Automation of a Human In Vitro Blood-Brain Barrier Model for the High-Throughput Screening of Compounds in the Early Stage of Drug Discovery. Pharmaceutics. 2021;13(6):892. doi: https://doi.org/10.3390/pharmaceutics13060892
- Salmina AB, Alexandrova OP, Averchuk AS, et al. Current progress and challenges in the development of brain tissue models: How to grow up the changeable brain in vitro? J Tissue Eng. 2024;15:20417314241235527. doi: https://doi.org/10.1177/20417314241235527
- Brofiga M, Massobrio P. Brain-on-a-Chip: Dream or Reality? Front Neurosci. 2022;16:837623. doi: https://doi.org/10.3389/fnins.2022.837623
- Maoz BM. Brain-on-a-Chip: Characterizing the next generation of advanced in vitro platforms for modeling the central nervous system. APL Bioeng. 2021;5(3):030902. doi: https://doi.org/10.1063/5.0055812
- Bang S, Jeong S, Choi N, et al. Brain-on-a-chip: A history of development and future perspective. Biomicrofluidics. 2019;13(5):051301. doi: https://doi.org/10.1063/1.5120555
- Park TE, Mustafaoglu N, Herland A, et al. Hypoxia-enhanced Blood-Brain Barrier Chip recapitulates human barrier function and shuttling of drugs and antibodies. Nat Commun. 2019;10(1):2621. doi: https://doi.org/10.1038/s41467-019-10588-0
- Cho H, Seo JH, Wong KH, et al. Three-Dimensional Blood-Brain Barrier Model for in vitro Studies of Neurovascular Pathology. Sci Rep. 2015;5:15222. doi: https://doi.org/10.1038/srep15222
- Hogberg HT, Smirnova L. The Future of 3D Brain Cultures in Developmental Neurotoxicity Testing. Front Toxicol. 2022;4:808620. doi: https://doi.org/10.3389/ftox.2022.808620
- Nikolakopoulou P, Rauti R, Voulgaris D, et al. Recent progress in translational engineered in vitro models of the central nervous system. Brain. 2020;143(11):3181–3213. doi: https://doi.org/10.1093/brain/awaa268
- Mäger I, Meyer AH, Li J, et al. Targeting blood-brain-barrier transcytosis — perspectives for drug delivery. Neuropharmacology. 2017;120:4–7. doi: https://doi.org/10.1016/j.neuropharm.2016.08.025
- Mitusova K, Peltek OO, Karpov TE, et al. Overcoming the blood-brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches. J Nanobiotechnology. 2022;20(1):412. doi: https://doi.org/10.1186/s12951-022-01610-7
- Adriani G, Ma D, Pavesi A, et al. A 3D neurovascular microfluidic model consisting of neurons, astrocytes and cerebral endothelial cells as a blood-brain barrier. Lab Chip. 2017;17(3):448–459. doi: https://doi.org/10.1039/c6lc00638h
- Cecen B, Saygili E, Zare I, et al. Biosensor integrated brain-on-a-chip platforms: Progress and prospects in clinical translation. Biosens Bioelectron. 2023;225:115100. doi: https://doi.org/10.1016/j.bios.2023.115100
- Ahn SI, Sei YJ, Park HJ, et al. Microengineered human blood-brain barrier platform for understanding nanoparticle transport mechanisms. Nat Commun. 2020;11(1):175. doi: https://doi.org/10.1038/s41467-019-13896-7
- Wei W, Cardes F, Hierlemann A, et al. 3D In Vitro Blood-Brain-Barrier Model for Investigating Barrier Insults. Adv Sci (Weinh). 2023;10(11):e2205752. doi: https://doi.org/10.1002/advs.202205752
Supplementary files





